Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday

Type 1 diabetes mellitus (T1D) is a chronic autoimmune disease in which destruction of the insulin-producing β-cells in the pancreatic islets requires regular lifelong insulin replacement therapy, the only lifesaving treatment available at this time. In young persons with a genetic predisposition, i...

Full description

Saved in:
Bibliographic Details
Main Authors: Livia M. R. Marcon, Carmine G. Fanelli, Riccardo Calafiore
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2022/9363543
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552648465711104
author Livia M. R. Marcon
Carmine G. Fanelli
Riccardo Calafiore
author_facet Livia M. R. Marcon
Carmine G. Fanelli
Riccardo Calafiore
author_sort Livia M. R. Marcon
collection DOAJ
description Type 1 diabetes mellitus (T1D) is a chronic autoimmune disease in which destruction of the insulin-producing β-cells in the pancreatic islets requires regular lifelong insulin replacement therapy, the only lifesaving treatment available at this time. In young persons with a genetic predisposition, it usually manifests after being exposed to environmental triggers. A subtype of autoimmune diabetes mellitus (ADM) that typically occurs in adulthood is often referred to as latent autoimmune diabetes of adults (LADA). LADA is characterized by a milder process of β-cells destruction and less intensive insulin treatment, which may become necessary even many years after diagnosis. Genetic predisposition of T1D carries an increased risk for other autoimmune diseases, such as autoimmune thyroiditis, the most frequently associated condition, and pernicious anaemia (PA), present in approximately 4% of all individuals with T1D. Here, we describe the case of a 90-year-old woman with vitiligo and a mute medical history who was admitted to our University Hospital in Perugia with hyperglycaemia and severe anaemia due to vitamin B12 (VB12) depletion. A short time after setting the beginning treatment with a basal-bolus insulin regimen, her insulin requirement rapidly declined and treatment with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP4), was started. A complete autoimmunity screening panel showed that GAD65 and intrinsic factor autoantibodies were positive.
format Article
id doaj-art-6f4d273dcbad4b078d177cd5643b9bb1
institution Kabale University
issn 2090-651X
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Endocrinology
spelling doaj-art-6f4d273dcbad4b078d177cd5643b9bb12025-02-03T05:58:10ZengWileyCase Reports in Endocrinology2090-651X2022-01-01202210.1155/2022/9363543Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a HolidayLivia M. R. Marcon0Carmine G. Fanelli1Riccardo Calafiore2Section of Endocrinology and MetabolismSection of Endocrinology and MetabolismSection of Endocrinology and MetabolismType 1 diabetes mellitus (T1D) is a chronic autoimmune disease in which destruction of the insulin-producing β-cells in the pancreatic islets requires regular lifelong insulin replacement therapy, the only lifesaving treatment available at this time. In young persons with a genetic predisposition, it usually manifests after being exposed to environmental triggers. A subtype of autoimmune diabetes mellitus (ADM) that typically occurs in adulthood is often referred to as latent autoimmune diabetes of adults (LADA). LADA is characterized by a milder process of β-cells destruction and less intensive insulin treatment, which may become necessary even many years after diagnosis. Genetic predisposition of T1D carries an increased risk for other autoimmune diseases, such as autoimmune thyroiditis, the most frequently associated condition, and pernicious anaemia (PA), present in approximately 4% of all individuals with T1D. Here, we describe the case of a 90-year-old woman with vitiligo and a mute medical history who was admitted to our University Hospital in Perugia with hyperglycaemia and severe anaemia due to vitamin B12 (VB12) depletion. A short time after setting the beginning treatment with a basal-bolus insulin regimen, her insulin requirement rapidly declined and treatment with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP4), was started. A complete autoimmunity screening panel showed that GAD65 and intrinsic factor autoantibodies were positive.http://dx.doi.org/10.1155/2022/9363543
spellingShingle Livia M. R. Marcon
Carmine G. Fanelli
Riccardo Calafiore
Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday
Case Reports in Endocrinology
title Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday
title_full Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday
title_fullStr Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday
title_full_unstemmed Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday
title_short Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday
title_sort type 1 diabetes t1d and latent autoimmune diabetes in adults lada the difference between a honeymoon and a holiday
url http://dx.doi.org/10.1155/2022/9363543
work_keys_str_mv AT liviamrmarcon type1diabetest1dandlatentautoimmunediabetesinadultsladathedifferencebetweenahoneymoonandaholiday
AT carminegfanelli type1diabetest1dandlatentautoimmunediabetesinadultsladathedifferencebetweenahoneymoonandaholiday
AT riccardocalafiore type1diabetest1dandlatentautoimmunediabetesinadultsladathedifferencebetweenahoneymoonandaholiday